Download PDF
Klin Monbl Augenheilkd 2003; 220(11): 738-753
DOI: 10.1055/s-2003-44613
Übersicht
© Georg Thieme Verlag Stuttgart · New York

Juvenile idiopathische Arthritis und Uveitis: Screening und antientzündliche Therapie

Juvenile Idiopathic Arthritis and Uveitis: Screening and Anti-Inflammatory TherapyArnd  Heiligenhaus1 , Anne  Mingels1 , Ulrich  Neudorf2 , Gerd  Ganser3
  • 1Augenabteilung am St.-Franziskus-Hospital, Münster
  • 2Universitätskinderklinik Essen
  • 3St.-Josef-Stift Sendenhorst, Abteilung Kinder- und Jugendrheumatologie
Further Information

Publication History

Eingegangen: 23. Juli 2003

Angenommen: 16. September 2003

Publication Date:
21 November 2003 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

In der Übersichtsarbeit werden die entzündlich-rheumatischen Erkrankungen im Kindesalter hinsichtlich Pathogenese, Epidemiologie, Diagnostik und klinischem Verlauf beschrieben. EULAR, ACR und die aktuelle ILAR-Klassifikation werden verglichen und die medikamentöse antientzündliche Therapie dargestellt. Es folgt eine Übersicht über die Uveitis bei den verschiedenen Arthritisformen. Die prognostischen Faktoren für das Auftreten einer Uveitis, der klinische Verlauf, die Komplikationen, die prognostischen Faktoren für Visusverlust sowie die antientzündliche Therapie werden behandelt. Die Empfehlungen der „Uveitis im Kindesalter - Studiengruppe” zu Screeninguntersuchung und Behandlung bei Uveitis bei juveniler idiopathischer Arthritis werden dargelegt und eine bundesweite Dokumentation dieser Patienten beschrieben.

Abstract

This article provides an overview of the rheumatic diseases in childhood, their pathogenesis, epidemiology, diagnosis and clinical course. EULAR, ACR and the current ILAR-classification are compared. The antiinflammatory medical treatment is described. The characteristics of uveitis in the various forms of arthritis are reviewed. The prognostic factors for uveitis manifestation, the clinical course, complications, the prognostic factors for visual loss, and the diverse antiinflammatory medical regimens are evaluated. The suggestions of the „uveitis in childhood study group” concerning screening and treatment of uveitis in patients with juvenile idiopathic arthritis are provided, and a nation-wide documentation of these patients is described.

Schlüsselwörter

Uveitis - juvenile idiopathische Arthritis - Iritis - Iridozyklitis - Immunsuppression

Key words

Uveitis - juvenile idiopathic arthritis - iritis - iridocyclitis - immunsuppression

Literatur

  • 1 Aasland A, Flato B, Vandvik I H. Psychosocial Outcome in Juvenile Chronic Arthritis: A nine year follow-up.  Clin Exp Rheumatol. 1997;  15 (5) 561-568
    PubMedGoogle Scholar
  • 2 Andersson G are. Juvenile arthritis - who gets it, where and when? A review of current data on incidence and prevalence.  Clin Exp Rheumatol. 1999;  17 (3) 367-374
    PubMedGoogle Scholar
  • 3 Bloch-Michel E, Nussenblatt R B. International uveitis study group recommentations for the evaluation of intraocular inflammatory disease.  Am J Ophthalmol. 1976;  103 234-235
    PubMedGoogle Scholar
  • 4 Breit W, Frosch M, Meyer U, Heinecke A, Ganser G. A subgroup specific evaluation of efficacy of triamcinolone-hexacetonide in juvenile chronic arthritis.  J Rheumatol. 2000;  27 2696-2702
    PubMedGoogle Scholar
  • 5 Brewer E J, Bass J, Baum J. et al . Current proposed revision of JRA criteria. JRA Criteria Subcommittee of the diagnostic and therapeutic criteria committee of the american rheumatism section of the arthritis foundation.  Arthritis Rheum. 1977;  20 195-199
    PubMedGoogle Scholar
  • 6 Cassidy J T, Sullivan D B, Petty R E. Clinical patterns of chronic iridocyclitis in children with juvenile rheumatoid arthritis.  Arthritis Rheum. 1977;  20 224-227
    PubMedGoogle Scholar
  • 7 Cassidy J T, Petty R E. Textbook of Pediatric Rheumatology, 4rd Edition, W. B. Saunders Co., Philadelphia American Academy of Pediatrics Section on rheumatology and section on ophthalmology. Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis.  Pediatrics. 1993;  92 295-296
    PubMedGoogle Scholar
  • 8 Cassidy J T, Petty R E. Textbook of Pediatric Rheumatology, 4rd Edition. Philadelphia; WB Saunders Co 2001
    Google Scholar
  • 9 Chalom E C, Goldsmith D P, Koehler M A. et al . Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis.  J Rheumatol. 1997;  24 2031-2034
    PubMedGoogle Scholar
  • 10 Chylack L T, Bienfang D C, Bellows A R, Stillmann J S. Ocular manifestations of juvenile rheumatoid arthritis.  Am J Ophthalmol. 1975;  79 1026-1033
    PubMedGoogle Scholar
  • 11 Chylack L T. The ocular manifestations of juvenile rheumatoid arthritis.  Arthritis Rheum. 1977;  20 217-223
    PubMedGoogle Scholar
  • 12 Cross A G. Uveitis in children.  Trans Ophthalmol Soc UK. 1965;  85 409-419
    PubMedGoogle Scholar
  • 13 Dana M R, Merayo-Lloves J, Schamberg D A, Foster C S. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis.  Ophthalmology. 1997;  104 236-244
    PubMedGoogle Scholar
  • 14 David J, Cooper C, Hickey L, Lloyd J, Dore C, McCullough C, Woo P. The functional and psychological outcomes of juvenile chronic arthritis in young adulthood.  Br J Rheumatol. 1994;  33 (9) 876-881
    PubMedGoogle Scholar
  • 15 Foster C S, Barrett F. Cataract development and cataract surgery in patients with juvenile rheumatoid arthritis-associated iridocyclitis (see comments).  Ophthalmology. 1993;  100 809-817
    PubMedGoogle Scholar
  • 16 Foster C S, Havrlikova K, Baltatzis S, Christen W G, Merayo-Lloves J. Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis.  Acta Ophthalmol Scand. 2000;  78 576-579
    CrossrefPubMedGoogle Scholar
  • 17 Frosch M, Herter B, Ganser G, Roth J, Harms E. Therapie der juvenilen chronischen Arthritis mit Sulfasalazin.  Monatschr Kinderheilkd. 1997;  145 724-728
    PubMedGoogle Scholar
  • 18 Ganser G, Zepp F, Wagner N. Juvenile Rheumatoide Arthritis. In: Schulte, Schaub, Lenze, Spranger (Hrsg) Lehrbuch der Pädiatrie. Berlin, Heidelberg, New York; Springer Verlag 2000: 587-600
    Google Scholar
  • 19 Ganser G. Physikalische Therapie bei juveniler chronischer Arthritis und Kollagenosen.  Akt Rheumatol. 2002;  27 213-220
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Giannini E H, Malagan C N, Kerckhove C van. et al . Longitudinal analysis of HLA associated risks for iridocyclitis in juvenile rheumatoid arthritis.  J Rheumatol. 1991;  18 1394-1397
    PubMedGoogle Scholar
  • 21 Giannini E H, Brewer E J, Kuzmina N. et al . Methotrexate in resistant juvenile rheumatoid arthritis: results of the U.S.A.-U.S.S.R. double blind, placebo-controlled trial.  N Engl J Med. 1992;  326 1043-1049
    PubMedGoogle Scholar
  • 22 Giordano M. Dauerprophylaxe der rezidivierenden „spondylitischen Iridozyklitis” durch Antimalarika und nichtsteroidale Antiphlogistika.  Z Rheumatol. 1983;  41 105-106
    PubMedGoogle Scholar
  • 23 Goel K M, Shanks R QA. Follow-up of 100 cases of juvenile rheumatoid arthritis.  Ann Rheum Dis. 1974;  33 25-31
    PubMedGoogle Scholar
  • 24 Halle F, Prieur A M. Evaluation of methotraxate in the treatment of juvenile chronic arthritis according to the subtype.  Clin Exp Rheumatol. 1991;  9 297-302
    PubMedGoogle Scholar
  • 25 Hemady R K, Baer J C, Foster C S. Immunosuppressive drugs in the management of progressive, corticosteroid-resistant uveitis associated with juvenile rheumatoid arthritis.  Int Ophthalmol Clin. 1992;  32 241-252
    CrossrefPubMedGoogle Scholar
  • 26 Henderly D E, Genstler A J, Smith R E, Rao N A. Changing patterns of uveitis.  Am J Ophthalmol. 1987;  103 131-136
    PubMedGoogle Scholar
  • 27 Horneff G, Forster J, Seyberth H W, Michels H. Empfehlungen der Arbeitsgemeinschaft Kinder- und Jugendrheumatologie zur Therapie mit Etanercept.  Monatschr Kinderheilkd. 2001;  149 1066-1069
    PubMedGoogle Scholar
  • 28 Ilowite N T. Current treatment of juvenile rheumatoid arthritis.  Pediatrics. 2002;  109 109-115
    CrossrefPubMedGoogle Scholar
  • 29 Kanski J J. Anterior uveitis in juvenile rheumatoid arthritis.  Arch Ophthalmol. 1977;  95 1794-1797
    PubMedGoogle Scholar
  • 30 Kanski J J, Shun-Shin G A. Systemic uveitis syndromes in childhood: an analysis of 340 cases.  Ophthalmology. 1984;  91 1247-1252
    PubMedGoogle Scholar
  • 31 Kanski J J. Uveitis in juvenile chronic arthritis: incidence, clinical features and prognosis.  Eye. 1988;  2 641-645
    PubMedGoogle Scholar
  • 32 Kanski J J. Screening for uveitis in juvenile chronic arthritis.  Br J Ophthalmol. 1989;  73 225-228
    PubMedGoogle Scholar
  • 33 Kanski J J. Juvenile arthritis and uveitis.  Surv Ophthalmol. 1990;  34 253-267
    PubMedGoogle Scholar
  • 34 Kanski J J. Lensectomy for complicated cataract in juvenile chronic iridocyclitis (see comments).  Br J Ophthalmol. 1992;  76 72-75
    PubMedGoogle Scholar
  • 35 Key S N, Kimura S J. Iridocyclitis associated with juvenile rheumatoid arthritis.  Am J Ophthalmol. 1975;  80 425-429
    PubMedGoogle Scholar
  • 36 Kilmartin D J, Forrester J V, Dick A D. Cyclosporin A therapy in refractory non-infectious childhood uveitis.  Br J Ophthalmol. 1998;  82 737-742
    CrossrefPubMedGoogle Scholar
  • 37 Kimura S J, Hogan M J, Thygeson P. Uveitis in children.  Arch Ophthalmol. 1954;  51 80-88
    PubMedGoogle Scholar
  • 38 Kimura S J, Hogan M J. Uveitis in children: analysis of 264 cases.  Trans Am Ophthalmol Soc. 1964;  62 173-192
    PubMedGoogle Scholar
  • 39 Kiessling U, Doring E, Listing J, Meincke J, Schontube M, Strangfeld A, Zink A. Incidence and prevalence of juvenile chronic arthritis in East Berlin 1980 - 88.  J Rheumatol. 1998;  25 (9) 1837-1843
    PubMedGoogle Scholar
  • 40 Kotaniemi K. Late onset uveitis in juvenile-type chronic polyarthritis controlled with prednisolone, cyclosporin A and methotrexat.  Clin Exp Rheumatol. 1998;  16 469-471
    PubMedGoogle Scholar
  • 41 Kotaniemi K, Kaipiainen-Seppanen O, Savolainen A, Karma A. A population-based study on uveitis in juvenile rheumatoid arthritis.  Clin Exp Rheumatol. 1999;  17 119-122
    PubMedGoogle Scholar
  • 42 Kotaniemi K, Kautiainen H, Karma A, Aho K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis. A prospective study.  Ophthalmology. 2001;  108 2071-2075
    CrossrefPubMedGoogle Scholar
  • 43 Kotaniemi K, Aho K, Kotaniemi A. Uveitis as a cause of visual loss in arthritis and comparable conditions.  J Rheumatol. 2001b;  28 309-312
    PubMedGoogle Scholar
  • 44 Koskull S von, Truckenbrodt H, Holle R, Hormann A. Incidence and prevalence of juvenile arthritis in an urban population of southern Germany: a prospective study.  Ann Rheum Dis. 2001;  60 (10) 940-945
    CrossrefPubMedGoogle Scholar
  • 45 Lazar M, Weiner M J, Leopold I H. Treatment of uveitis with methotrexate.  Am J Ophthalmol. 1969;  67 383-387
    PubMedGoogle Scholar
  • 46 Leak A M, Woo P. Juvenile chronic arthritis, chronic iridocyclitis, and reactivity to histones.  Ann Rheum Dis. 1991;  50 653-657
    PubMedGoogle Scholar
  • 47 Lovell D J, Giannini E H, Reiff A. et al . Etanercept in children with polyarticular juvenile rheumatoid arthritis.  N Engl J Med. 2000;  342 763-769
    CrossrefPubMedGoogle Scholar
  • 48 Malagon C, Kerckhove C, Giannini E H. et al . The iridocyclitis of early onset pauciarticular juvenile rheumatoid arthritis: outcome in immunogenetically characterized patients.  J Rheumatol. 1992;  19 160-163
    PubMedGoogle Scholar
  • 49 Michels H. Pharmakotherapie bei rheumatischen Erkrankungen im Kindesalter.  Praktische Pädiatrie. 2001;  5 278-288
    PubMedGoogle Scholar
  • 50 Minden K, Kiessling U, Listing J, Niewerth M, Döring E, Meincke J, Schöntube M, Zink A. Prognosis of patients with juvenile chronic arthritis and juvenile spondylarthropathy.  J Rheumatol. 2000;  27 2256-2263
    PubMedGoogle Scholar
  • 51 Ohno S, Char D H, Kimura S J, O'Connor G R. HLA antigens and antinuclear antibody titres in juvenile chronic iridocyclitis.  Br J Ophthalmol. 1977;  61 59-61
    PubMedGoogle Scholar
  • 52 Olson N Y, Lindsey C B, Godfrey W A. Nonsteroidal anti-inflammatory drug therapy in chronic childhood iridocyclitis.  Am J Dis Chil. 1988;  142 1289-1292
    PubMedGoogle Scholar
  • 53 Paivonsalo-Hietanen T, Tuominen J, Saari K M. Uveitis in children: population-based study in Finland.  Acta Ophthalmol Scand. 2000;  78 84-88
    CrossrefPubMedGoogle Scholar
  • 54 Perkins E S. Pattern of uveitis in children.  Br J Ophthalmol. 1966;  50 169-185
    PubMedGoogle Scholar
  • 55 Petty R E, Cassidy J T, Sullivan D B. Clinical correlates of antinuclear antibodies in juvenile rheumatoid arthritis.  J Pediatr. 1973;  83 386-389
    CrossrefPubMedGoogle Scholar
  • 56 Petty R E, Southwood T R, Baum J, Bhettay E, Glass D N, Manners P, Maldonado-Cocco J, Suarez-Almazor M, Orozco-Alcala J, Prieur A M. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997.  J Rheumatol. 1998;  25 (10) 1991-1994
    PubMedGoogle Scholar
  • 57 Ramadan A, Nussenblatt R. Cytotoxic agents in ocular inflammation.  Ophthalmol Clin North Am. 1997;  10 377-387
    PubMedGoogle Scholar
  • 58 Reiff A, Takei S, Sadeghi S. et al . Etanercept therapy in children with treatment-resistant uveitis.  Arthritis Rheum. 2001;  44 1411-1415
    CrossrefPubMedGoogle Scholar
  • 59 Rosenberg A M, Oen K G. The relationship between ocular and articular disease activity in children with juvenile rheumatoid arthritis and associated uveitis.  Arthritis Rheum. 1986;  29 797-800
    PubMedGoogle Scholar
  • 60 Rosenberg A M, Oen K G. The relationsship between ocular and articular disease activity in children with juvenile rheumatoid arthritis and associated uveitis.  Arthritis Rheum. 1986;  29 797-800
    PubMedGoogle Scholar
  • 61 Rosenberg A M. Uveitis associated with juvenile rheumatoid arthritis.  Semin Arthritis Rheum. 1987;  16 158-173
    CrossrefPubMedGoogle Scholar
  • 62 Rothova A, Buitenhuis H J, Meenken C. et al . Uveitis and systemic disease.  Br J Ophthalmol. 1992;  76 137-141
    CrossrefPubMedGoogle Scholar
  • 63 Ruperto N, Levinson J E, Ravelli A, Shear E S, Link Tague B, Murray K, Martini A, Giannini E H. Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status.  J Rheumatol. 1997;  24 (5) 945-951
    PubMedGoogle Scholar
  • 64 Ruperto N, Ravelli A, Levinson J E, Shear E S, Murray K, Link Tague B, Martini A, Glass D N, Giannini E H. Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. II. Early predictors of outcome.  J Rheumatol. 1997;  24 (5) 952-958
    PubMedGoogle Scholar
  • 65 Samson C M, Waheed N, Baltatzis S, Foster C S. Methotrexate therapy for chronic noninfectious uveitis. Analysis of a case series of 160 patients.  Ophthalmology. 2001;  108 1134-1139
    CrossrefPubMedGoogle Scholar
  • 66 Sand B B, Krogh E. Topical indomethacin, a prostaglandin inhibitor, in acute anterior uveitis. A controlled clinical trial of non-steroid versus steroid anti-inflammatory treatment.  Acta Ophthalmol. 1991;  69 145-148
    PubMedGoogle Scholar
  • 67 Savolainen H A, Kautianen H, Isomaki H, Aho K, Verronen P. Azathioprin in patients with juvenile chronic arthritis: a long-term follow-up study.  J Rheumatol. 1997;  24 2444-2450
    PubMedGoogle Scholar
  • 68 Schaller J G, Johnson G D, Holborow E J. et al . The association of antinuclear antibodies with the chronic iridocyclitis of juvenile rheumatoid arthritis (Still's disease).  Arthritis Rheumatol. 1974;  17 409-416
    PubMedGoogle Scholar
  • 69 Schaller J G. Juvenile rheumatoid arthritis: series 1.  Arthritis Rheumatol. 1977;  20 165-170
    PubMedGoogle Scholar
  • 70 Schneider R, Passo M H. Juvenile rheumatoid arthritis.  Rheum Dis Clin N Am. 2002;  28 503-530
    PubMedGoogle Scholar
  • 71 Sherry D D, Mellins E D, Wedgewood R J. Decreasing severity of chronic uveitis in children with pauciarticular arthritis.  Am J Dis Child. 1991;  145 1026-1028
    PubMedGoogle Scholar
  • 72 Shetty A K, Zganjar B E, Ellis G S. et al . Low-dose methotrexate in the treatment of severe juvenile rheumatoid arthritis and sarcoid iritis.  J Pediatr Ophthalmol Strabismus. 1999;  36 125-128
    PubMedGoogle Scholar
  • 73 Smiley W K. The visual prognosis in Still's disease with eye involvement.  Proc R Soc Med. 1960;  53 196-199
    PubMedGoogle Scholar
  • 74 Smiley W K. The eye in juvenile rheumatoid arthritis.  Trans Ophthalmol Soc UK. 1974;  94 817-829
    PubMedGoogle Scholar
  • 75 Smith J R, Levinson R D, Holland G N. et al . Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.  Arthritis Rheum. 2001;  45 252-257
    CrossrefPubMedGoogle Scholar
  • 76 Southwood T R, Malleson P N. Antinuclear antibodies and chronic arthritis (JCA): search for a specific autoantibody associated with JCA.  Ann Rheum Dis. 1991;  50 595-598
    PubMedGoogle Scholar
  • 77 Spalter H F. The visual prognosis in juvenile rheumatoid arthritis.  Trans Am Ophthalmol Soc. 1975;  73 554-570
    PubMedGoogle Scholar
  • 78 Speckmaier M, Findeisen J, Woo P. et al . Low-dose methotrexate in systemic onset juvenile chronic arthritis.  Clin Exp Rheumatol. 1989;  7 647-650
    PubMedGoogle Scholar
  • 79 Stoeber E. Prognosis in Juvenile Chronic Arthritis.  Eur J Pediatr. 1981;  135 225-228
    CrossrefPubMedGoogle Scholar
  • 80 Tugal-Tutkun I, Havrlikova K, Power W J, Foster C S. Changing patterns in uveitis of childhood.  Ophthalmology. 1996;  103 375-383
    PubMedGoogle Scholar
  • 81 Vesterdal E, Sury B. Iridocyclitis and bandshaped corneal opacity in juvenile rheumatoid arthritis.  Acta Ophthalmol (Copenh). 1950;  28 321-327
    PubMedGoogle Scholar
  • 82 Wakefield D, McCluskey P, Penny R. Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease.  Arch Ophthalmol. 1986;  104 874-851
    PubMedGoogle Scholar
  • 83 Wallace C A, Bleyer W A, Sherry D D. et al . Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis.  Arthritis Rheum. 1989;  32 677-681
    PubMedGoogle Scholar
  • 84 Wallace C A, Levinson J E. Juvenile Rheumatoid Arthritis: Outcome and Treatment for the 1990's.  Rheum Disease Clinics of North Am. 1991;  17 891-905
    PubMedGoogle Scholar
  • 85 Weiss A H, Wallace C A, Sherry D D. Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis.  J Pediatr. 1998;  133 266-268
    PubMedGoogle Scholar
  • 86 Wolf M D, Lichter P R, Ragsdale C G. Prognostic factors in the uveitis of juvenile rheumatoid arthritis.  Ophthalmology. 1987;  94 1242-1248
    PubMedGoogle Scholar
  • 87 Young B J, Cunningham W F, Akingkein T. Double-masked, controlled clinical trial of 5 % tolmetin versus 0,5 % prednisolone versus 0,9 % saline in acute endogenous nongranulomatous anterior uveitis.  Br J Ophthalmol. 1982;  26 389-391
    PubMedGoogle Scholar
  • 88 Zak M, Pederson F K. Juvenile chronic arthritis into adulthood: a long-term follow-up study.  Rheumatology. 2000;  39 198-204
    CrossrefPubMedGoogle Scholar

1 Die Empfehlungen wurden erarbeitet unter Mitwirkung von: Ophthalmologie: M. Becker, A. Heiligenhaus, T. Hudde, U. Pleyer, K.-P. Steuhl, S. Thurau, M. Zierhut. Pädiatrie: S. Benseler, G. Bürk, S. Fahl, D. Föll, M. Frosch, G. Ganser, S. Kastner, I. Kleine, E. Lainka, K. Mönkemöller, J. Ndagijimana, U. Neudorf, T. Niehues, J. Roth, S. Seeliger, N. Wagner, R. Wieland, H. Winowski.

2 Die Empfehlungen wurden erarbeitet unter Mitwirkung von: Ophthalmologie: M. Becker, A. Heiligenhaus, T. Hudde, U. Pleyer, K.-P. Steuhl, S. Thurau, M. Zierhut. Pädiatrie: S. Benseler, G. Bürk, S. Fahl, D. Föll, M. Frosch, G. Ganser, S. Kastner, I. Kleine, E. Lainka, K. Mönkemöller, J. Ndagijimana, U. Neudorf, T. Niehues, J. Roth, S. Seeliger, N. Wagner, R. Wieland, H. Winowski.

Prof. Dr. med. Arnd Heiligenhaus

Augenabteilung am St.-Franziskus-Hospital

Hohernzollernring 74

48145 Münster

Email: arnd.heiligenhaus@t-online.de

      >